“A phase III, randomized, placebo- controlled, clinical trial to evaluate the efficacy and safety of co-administered niclosamide in patients treated with an established regimen for novel coronavirus infectious disease (COVID- 19)”


Mete A. Ö., Avkan Oğuz V., Tunçok Y., Nazlı Zeka A., Kılınç O., Gökmen A. N.

Project Supported by Other Private Institutions, 2020 - 2021

  • Project Type: Project Supported by Other Private Institutions
  • Begin Date: October 2020
  • End Date: February 2021